Pinnacle Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.15M Buy
10,808
+325
+3% +$34.5K 0.02% 477
2025
Q1
$1.3M Sell
10,483
-100
-0.9% -$12.4K 0.02% 443
2024
Q4
$1.3M Buy
10,583
+322
+3% +$39.7K 0.02% 437
2024
Q3
$1.26M Sell
10,261
-77
-0.7% -$9.47K 0.02% 428
2024
Q2
$1.1M Sell
10,338
-33
-0.3% -$3.52K 0.02% 451
2024
Q1
$1.25M Buy
10,371
+110
+1% +$13.2K 0.02% 447
2023
Q4
$1.26M Sell
10,261
-326
-3% -$40.1K 0.02% 435
2023
Q3
$1.37M Buy
10,587
+238
+2% +$30.8K 0.03% 411
2023
Q2
$1.28M Buy
10,349
+1,308
+14% +$162K 0.02% 430
2023
Q1
$1.32M Buy
9,041
+3,561
+65% +$521K 0.03% 368
2022
Q4
$873K Buy
5,480
+5
+0.1% +$797 0.02% 415
2022
Q3
$730K Sell
5,475
-150
-3% -$20K 0.02% 445
2022
Q2
$878K Sell
5,625
-185
-3% -$28.9K 0.02% 431
2022
Q1
$904K Buy
5,810
+3,930
+209% +$611K 0.02% 463
2021
Q4
$240K Buy
1,880
+141
+8% +$18K ﹤0.01% 719
2021
Q3
$226K Buy
1,739
+260
+18% +$33.8K ﹤0.01% 704
2021
Q2
$263K Buy
1,479
+139
+10% +$24.7K ﹤0.01% 677
2021
Q1
$220K Sell
1,340
-100
-7% -$16.4K ﹤0.01% 683
2020
Q4
$238K Hold
1,440
﹤0.01% 639
2020
Q3
$205K Buy
+1,440
New +$205K ﹤0.01% 637
2020
Q1
Sell
-1,340
Closed -$200K 690
2019
Q4
$200K Buy
+1,340
New +$200K ﹤0.01% 667
2017
Q3
Sell
-1,380
Closed -$215K 679
2017
Q2
$215K Sell
1,380
-240
-15% -$37.4K ﹤0.01% 630
2017
Q1
$235K Buy
+1,620
New +$235K ﹤0.01% 603
2016
Q4
Sell
-1,802
Closed -$219K 640
2016
Q3
$219K Sell
1,802
-115
-6% -$14K ﹤0.01% 587
2016
Q2
$271K Sell
1,917
-130
-6% -$18.4K 0.01% 554
2016
Q1
$267K Sell
2,047
-40
-2% -$5.22K 0.01% 538
2015
Q4
$293K Sell
2,087
-93
-4% -$13.1K 0.01% 541
2015
Q3
$290K Sell
2,180
-50
-2% -$6.65K 0.01% 531
2015
Q2
$393K Sell
2,230
-20
-0.9% -$3.53K 0.01% 502
2015
Q1
$389K Buy
2,250
+135
+6% +$23.3K 0.01% 507
2014
Q4
$346K Buy
+2,115
New +$346K 0.01% 507